CSL Seqirus ships first flu vaccines for the 2026/27 season in USA
Australia’s CSL Limited subsidiary CSL Seqirus has started shipping influenza vaccines to health care providers in the USA, helping them get prepared for the upcoming flu season, to target the H3N2 subclade K strain that drove last season’s historic surge.